Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ALLR Allarity Therapeutics Inc

1,49

0,22 (17,32%)

02 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Allarity Therapeutics Charts.

News Allarity Therapeutics Inc

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
Montag 29 April 2024 (3 Tage vor) • GlobeNewswire Inc.

Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
Mittwoch 17 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
Donnerstag 4 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
Mittwoch 27 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
Freitag 8 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Allarity Therapeutics to Present at Biomarkers 2024
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Allarity Therapeutics Inc News-Artikel

Financial Select Sector

JP Morgan Chase

Health Care Select Sector

Euro vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen